1 3 Fig. 4 Mouse embryonic NSCs were treated with 1 mM VPA for up to 7 days and immunostained with anti-β-tubulin-III, anti-MAP-2, anti-CNPase, and anti-GFAP. Scale bar 100 μm
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Fig. 7
Mouse embryonic NSCs were treated with 1 mM VPA for up to 7 days in the absence or presence of 10 µM SP600125 and immunostained with anti-β-tubulin-III, anti-MAP-2, anti-CNPase, and anti-GFAP. Scale bar 100 μm
